- Home
- CLM vs SDGR Comparison
CLM vs SDGR Comparison
Compare CLM & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLM
- SDGR
- Stock Information
- Founded
- CLM 1987
- SDGR 1990
- Country
- CLM United States
- SDGR United States
- Employees
- CLM N/A
- SDGR N/A
- Industry
- CLM Finance/Investors Services
- SDGR Biotechnology: Pharmaceutical Preparations
- Sector
- CLM Finance
- SDGR Health Care
- Exchange
- CLM Nasdaq
- SDGR Nasdaq
- Market Cap
- CLM 1.9B
- SDGR 1.7B
- IPO Year
- CLM N/A
- SDGR 2020
- Fundamental
- Price
- CLM $7.78
- SDGR $21.62
- Analyst Decision
- CLM
- SDGR Buy
- Analyst Count
- CLM 0
- SDGR 5
- Target Price
- CLM N/A
- SDGR $32.80
- AVG Volume (30 Days)
- CLM 1.4M
- SDGR 1.2M
- Earning Date
- CLM 01-01-0001
- SDGR 05-07-2025
- Dividend Yield
- CLM 18.74%
- SDGR N/A
- EPS Growth
- CLM N/A
- SDGR N/A
- EPS
- CLM N/A
- SDGR N/A
- Revenue
- CLM N/A
- SDGR $230,492,000.00
- Revenue This Year
- CLM N/A
- SDGR $24.71
- Revenue Next Year
- CLM N/A
- SDGR $17.64
- P/E Ratio
- CLM N/A
- SDGR N/A
- Revenue Growth
- CLM N/A
- SDGR 22.29
- 52 Week Low
- CLM $6.25
- SDGR $16.60
- 52 Week High
- CLM $8.84
- SDGR $28.47
- Technical
- Relative Strength Index (RSI)
- CLM 69.22
- SDGR 41.07
- Support Level
- CLM $7.18
- SDGR $21.13
- Resistance Level
- CLM $7.46
- SDGR $22.00
- Average True Range (ATR)
- CLM 0.13
- SDGR 1.03
- MACD
- CLM 0.05
- SDGR -0.23
- Stochastic Oscillator
- CLM 99.26
- SDGR 30.11
About CLM Cornerstone Strategic Value Fund Inc. New
Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, industrials, utilities, energy, telecommunication services, materials, and other sectors.
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.